Literature DB >> 934239

Pharmacokinetic aspects of theophylline in premature newborns.

J V Aranda, D S Sitar, W D Parsons, P M Loughnan, A H Neims.   

Abstract

To characterize further the pharmacokinetics of theophylline in premature infants, its concentraion in blood was measured by high-pressure liquid chromatography after intravenous infusion given to six apneic premature newborns three to 15 days of age. Theophylline's apparent volume of distribution was 0.690 +/- 0.095 liters per kilogram (mean +/- S.E.), a value similar to that of children, but the half-life (30.2 +/- 6.5 hours) was nine times longer. Blood clearance rate (17.6 +/- 2.3 ml per kilogram per hour) was lower than plasma clearance rate (100 ml per kilogram per hour) of young children. At a total plasma concentration of 17 mg per liter, 56.4 +/- 3.8 and 36.4 +/- 3.8 per cent of the theophylline was bound to adult or full-term cord plasma proteins, respectively. Bilirubin and theophylline did not compete for plasma protein. Calculations suggest that a loading doses of 5.5 mg per kilogram and a maintenance dose rate of 1.1 mg per kilogram per eight hours would achieve and maintain a mean blood concentration of 8 mg per liter (about 10 mg per liter in plasma).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 934239     DOI: 10.1056/NEJM197608192950803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  54 in total

Review 1.  Review: therapeutic drug monitoring in pediatrics.

Authors:  Offie Porat Soldin; Steven J Soldin
Journal:  Ther Drug Monit       Date:  2002-02       Impact factor: 3.681

Review 2.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

3.  Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline.

Authors:  R C Kolbeck; W A Speir; G O Carrier; E D Bransome
Journal:  Lung       Date:  1979       Impact factor: 2.584

4.  Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver.

Authors:  Barent DuBois; Samantha Louey; George D Giraud; Ganesh Cherala; Sonnet S Jonker
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-03-19       Impact factor: 4.080

Review 5.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

6.  Microdialysis sampling for determination of plasma protein binding of drugs.

Authors:  A M Herrera; D O Scott; C E Lunte
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

Review 7.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

8.  Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.

Authors:  Hussain Mulla; Fazal Nabi; Sanjiv Nichani; Graham Lawson; R K Firmin; David R Upton
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

Review 9.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

10.  Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppositories.

Authors:  P Bolme; P O Edlund; M Eriksson; L Paalzow; B Winbladh
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.